{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:41Z","timestamp":1761895301156},"reference-count":26,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ejca.2011.05.004","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T21:08:52Z","timestamp":1308604132000},"page":"1919-1927","source":"Crossref","is-referenced-by-count":23,"title":["Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways"],"prefix":"10.1016","volume":"47","author":[{"given":"Voralak","family":"Vichapat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Fentiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Tutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet","family":"L\u00fcchtenborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2011.05.004_b0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6605148","article-title":"Cancer prevalence in the United Kingdom: estimates for 2008","volume":"101","author":"Maddams","year":"2009","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2011.05.004_b0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.ede.0000072105.39021.6d","article-title":"The descriptive epidemiology of second primary breast cancer","volume":"14","author":"Bernstein","year":"2003","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.ejca.2011.05.004_b0015","first-page":"855","article-title":"Epidemiology of contralateral breast cancer","volume":"8","author":"Chen","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"8","key":"10.1016\/j.ejca.2011.05.004_b0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/oxfordjournals.aje.a116565","article-title":"Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer","volume":"136","author":"Bernstein","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.ejca.2011.05.004_b0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1053\/ejso.1999.0711","article-title":"Clinical and histological predictors of contralateral breast cancer","volume":"25","author":"Kollias","year":"1999","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2011.05.004_b0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.bjc.6601042","article-title":"Epidemiologic and molecular risk factors for contralateral breast cancer among young women","volume":"89","author":"Li","year":"2003","journal-title":"Br J Cancer"},{"issue":"9114","key":"10.1016\/j.ejca.2011.05.004_b0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group","volume":"351","author":"Group EBCTC","year":"1998","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejca.2011.05.004_b0040","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/83.18.1299","article-title":"Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy","volume":"83","author":"Rutqvist","year":"1991","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.ejca.2011.05.004_b0045","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.ejca.2009.05.022","article-title":"Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial","volume":"45","author":"Alkner","year":"2009","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.ejca.2011.05.004_b0050","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jnci\/87.18.1359","article-title":"Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers","volume":"87","author":"Cook","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.ejca.2011.05.004_b0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6600746","article-title":"The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer","volume":"88","author":"Kaas","year":"2003","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.ejca.2011.05.004_b0060","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1158\/0008-5472.CAN-09-1355","article-title":"Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.ejca.2011.05.004_b0065","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jnci\/93.13.1008","article-title":"Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer","volume":"93","author":"Li","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ejca.2011.05.004_b0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djh097","article-title":"Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer","volume":"96","author":"Swain","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2011.05.004_b0075","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/0008-5472.CAN-06-3854","article-title":"Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk","volume":"67","author":"Hemminki","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2011.05.004_b0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF00052945","article-title":"A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)","volume":"7","author":"Cook","year":"1996","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.ejca.2011.05.004_b0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0021-9681(87)90114-7","article-title":"Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut Tumor Registry","volume":"40","author":"Horn","year":"1987","journal-title":"J Chronic Dis"},{"issue":"7","key":"10.1016\/j.ejca.2011.05.004_b0090","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","article-title":"Contralateral breast cancer: annual incidence and risk parameters","volume":"13","author":"Broet","year":"1995","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2011.05.004_b0095","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1993.11.8.1545","article-title":"Contralateral breast cancer: clinical characteristics and impact on prognosis","volume":"11","author":"Healey","year":"1993","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2011.05.004_b0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1097-0142(19880715)62:2<412::AID-CNCR2820620228>3.0.CO;2-3","article-title":"Risk of contralateral breast cancer. Associations with histologic, clinical, and therapeutic factors","volume":"62","author":"Horn","year":"1988","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2011.05.004_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/bjc.1984.12","article-title":"Second primary cancers of the breast: incidence and risk factors","volume":"49","author":"Hislop","year":"1984","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2011.05.004_b0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9610(82)90540-2","article-title":"Incidence of lobular carcinoma in bilateral breast cancer","volume":"144","author":"Lewis","year":"1982","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.ejca.2011.05.004_b0115","first-page":"743","article-title":"Clonal analysis of bilateral breast cancer","volume":"2","author":"Shibata","year":"1996","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejca.2011.05.004_b0120","first-page":"773","article-title":"Efficacious diagnosis of primary and metastatic human carcinomas with a combination of p53 mutation analysis and clonality analysis of androgen receptor gene","volume":"13","author":"Aotake","year":"1998","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2011.05.004_b0125","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjc.6602021","article-title":"Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis","volume":"91","author":"Teixeira","year":"2004","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2011.05.004_b0130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1245\/s10434-009-0841-6","article-title":"Lymphatic drainage patterns from the treated breast","volume":"17","author":"van der Ploeg","year":"2010","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911003212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911003212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T22:34:24Z","timestamp":1560292464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804911003212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0959804911003212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.05.004","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}